Altered proteostasis, endoplasmic reticulum (ER) stress, abnormal unfolded protein response (UPR), mitochondrial dysfunction and autophagy impairment are interconnected events, which contribute to the pathogenesis of amyotrophic lateral sclerosis (ALS)/frontotemporal dementia (FTD). In recent years, the mood stabilizer lithium was shown to potentially modify ALS/FTD beyond mood disorder-related pathology. The effects of lithium are significant in ALS patients carrying genetic variations in the UNC13 presynaptic protein, which occur in ALS/FTD and psychiatric disorders as well. In the brain, lithium modulates a number of biochemical pathways involved in synaptic plasticity, proteostasis, and neuronal survival. By targeting UPR-related events, namely ER stress, excitotoxicity and autophagy dysfunction, lithium produces plastic effects. These are likely to relate to neuroprotection, which was postulated for mood and motor neuron disorders. In the present manuscript, we try to identify and discuss potential mechanisms through which lithium copes concomitantly with ER stress, UPR and autophagy dysfunctions related to UNC13 synaptic alterations and aberrant RNA and protein processing. This may serve as a paradigm to provide novel insights into the neurobiology of ALS/FTD featuring early psychiatric disturbances.
Editors
2
Impact
Loading...
Mini Review
04 October 2019
Fiona Limanaqi
, 3 more and
Francesco Fornai
Original Research
08 January 2020
Yang Shen
, 12 more and
Jianzhong Bi
5,644 views
32 citations
Review
29 September 2020
Vignesh Srinivasan
, 1 more and
Dan Lindholm
6,584 views
11 citations
Review
31 August 2021
Mahmoud Suliman
, 1 more and
Miriam L. Greenberg
5,531 views
11 citations
Original Research
05 November 2019
Lei Xia
, 14 more and
Changlian Zhu
3,579 views
16 citations
Open for submission
Frontiers in Cellular Neuroscience
Anxiety and Depression Disorders: The Role of Glial CellsEdited by America Vanoye-Carlo, Gabriel Gutiérrez-Ospina
Deadline
25 June 2025
Recommended Research Topics